Brabantse Ontwikkelings Maatschappij
Edit

Brabantse Ontwikkelings Maatschappij

https://www.bom.nl
Last activity: 27.05.2025
Active
The Brabant Development Agency (BOM) works together with entrepreneurs to create a future-proof Brabant economy. We share knowledge, develop networks, and provide capital to innovative Brabant companies and sustainable energy projects.

We also encourage forward-looking international companies to settle in Brabant and assist companies already based in Brabant to extend their reach abroad.
Our goals include further economic growth, increased employment, solutions to social issues, and a leading role for Brabant on the world stage.

BOM Brabant Ventures
With the help of its unique knowledge and capital, BOM uses the Brabant Ventures label to focus on the accelerated and future-proof growth of ambitious Brabant startups and scaleups in the High-Tech Systems and Software, Agri-food, Life Sciences & Health, Maintenance, Supply Chain, and Bio-based Economy top industries.

BOM International Trade
Under the International Trade label BOM assists Brabant companies to make the best possible use of their opportunities on international markets and to increase their growth.

BOM Foreign Investments
Under its Foreign Investments label BOM aids foreign companies in the High-Tech, Life Sciences & Health, Supply Chain, Agri-food, Chemicals, and Aerospace industries to make best use of the opportunities offered by Brabant as a base for operations.

BOM Renewable Energy
Under its Renewable Energy label BOM provides knowledge, capital and access to its network to develop and invest in renewable energy projects.
Likes
105
Portfolio
4
Mentions
53
Location: Netherlands, North Brabant, Tilburg
Employees: 51-200
Phone:+31 88 831 1120
Founded date: 1983
Investment Type: Venture Capital; Accelerator

Portfolio 4

DateNameWebsiteTotal RaisedLocation
08.08.2023Post-ICU, ...post-icu.com$1.09MUnited Sta...
13.06.2023VIVOLTAvivolta.com$7.59MNetherland...
29.03.2023Sirius Med...sirius-medical.com$28.31MNetherland...
12.07.2022Cloudprint...cloudprinter.com$7.01MNetherland...

Mentions in press and media 53

DateTitleDescription
29.05.2025Salvia BioElectronics: A New Dawn for Migraine SufferersIn the world of chronic pain, migraines reign supreme. They are not just headaches; they are life-altering storms that can sweep away productivity, joy, and social connections. For millions, the search for relief is a relentless journey. En...
27.05.2025Migraines? This Dutch startup just raised €53 million to transform migraine treatment with its ultra-thin implantEindhoven-based Salvia BioElectronics, a clinical-stage medical device company innovating neuromodulation therapy for patients with chronic migraine, today announced the successful completion of their €53 million Series B financing round. T...
08.05.2025Eyeo's €15 Million Seed Round: A New Dawn for Image SensorsIn the bustling tech landscape, innovation often feels like a race against time. The latest contender to make waves is Eyeo, a Dutch startup that has just secured €15 million in seed funding. This investment is not just a financial boost; i...
07.05.2025Imaging startup Eyeo raises €15M to for colour-splitting sensor techDutch startup Eyeo has secured €15M in an oversubscribed seed round to commercialise a new approach to image sensor design that promises to boost light sensitivity, color accuracy, and resolution. The round was co-led by imec.xpand and Dutc...
04.02.2025Sirius Medical Raises €10M in Additional FundingSirius Medical, an Eindhoven, the Netherlands-based medical device company, raised €10M in additional funding. The round was led by Invest-NL and Nextgen Ventures, with support from De Groot Family Office and existing investors Brabant Deve...
10.12.2024Citryll's €85 Million Boost: A New Dawn for Inflammatory Disease TreatmentIn the world of biotech, funding is the lifeblood. Recently, Dutch startup Citryll secured a significant €85 million in Series B funding. This financial windfall is not just a number; it represents hope for countless patients battling immun...
09.12.2024Citryll Raises EUR 85M in Series B FundingCitryll, an Oss, The Netherlands-based biotech company developing a new approach to treating immune-mediated inflammatory diseases by targeting Neutrophil Extracellular Traps (NETs), raised €85M in Series B funding. The round was led by Joh...
09.12.2024Oss-based Citryll secures €85 million Series B funding to advance NET-targeting therapyDutch startup Citryll, a biotech innovator in immune-mediated inflammatory diseases, has raised €85 million in a Series B funding round. The financing was co-led by Johnson & Johnson Innovation (through its corporate venture capital org...
29.10.2024RIFT: €11 Million (Series A) Raised To Decarbonize Energy-Intensive Industries With Iron FuelRIFT (Renewable Iron Fuel Technology) announced it closed a € 11 million Series A funding round €. Pension investor PGGM (on behalf of the Dutch healthcare pension fund, PFZW), Invest-NL, and Oost NL have joined as new investors. Existing s...
16.10.2024The Rise of Photonics: A New Era of Innovation in the NetherlandsThe Netherlands is becoming a beacon for photonics innovation. Recent investments are fueling a surge in this high-tech sector. PhotonVentures and SuperLight Photonics are at the forefront of this movement. They are not just companies; they...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In